• Results of a preclinical, proof-of-concept study led by VHIO’s Stem Cells and Cancer Group demonstrate for the first time the promise of systemic targeted therapy in patients with pseudomyxoma ...

Pseudomyxoma peritonei (PMP) is a type of tumor characterized by the progressive dissemination of jelly-like ascites and mucinous tumor in the peritoneum. PMP is a rare disease with an approximate ...

Pseudomyxoma peritonei is a rare disease and treatment can be difficult. Cytoreductive surgery with intraperitoneal chemotherapy has been proposed as a curative treatment. To evaluate the efficacy and ...

5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) as postoperative adjuvant chemotherapy (CT) for node-positive rectal cancer after radiochemotherapy (R-CT) and surgery. Background: Inflammatory ...

Since then quite an extensive literature has accumulated concerning this comparatively infrequent process. It is now well established that "pseudomyxoma peritonei" is not a disease in itself but an ...